Kathleen Neuzil, MD, MPH, FIDSA, Professor of Medicine and Pediatrics, is Director of the Center for Vaccine Development and Global Health. Dr. Neuzil is one of the world’s preeminent scientists and advocates in vaccine science and policy. Throughout her career, she has conducted clinical and epidemiologic studies on vaccine-preventable diseases, including work on influenza and rotavirus, that have informed domestic and international vaccine policy.
Dr. Kotloff is Professor of Pediatrics and a pediatric infectious disease specialist. She has served as Principal Investigator on some of the largest projects related to child health and mortality prevention. Her research covers respiratory diseases such as pneumonia as well as research into enteric diseases such as rotavirus, Shigella, cholera and typhoid. Dr. Kotloff’s research has been instrumental in helping to set prevention policy including a strong footing for vaccine development and distribution in low-resource global settings.
Dr. Laufer is Professor of Pediatrics and a pediatric infectious diseases specialist with over 15 years of experience in conducting epidemiological and translational research with a focus of translating scientific discovery into clinically relevant strategies to improve the health of people living in malaria-endemic countries. Much of her work has focused on maternal immunization as well as drug-resistance. Dr. Laufer leads a team of dynamic and world-renowned researchers who work towards accelerating malaria elimination.
Dr. Sztein is Professor of Pediatrics and Associate Director for Immunologic Studies. He established the Immunology Group to centralize and expand interdisciplinary efforts in translational research, a “bench to bedside” program with the ultimate goal of accelerating vaccine development and usage. He is an accomplished investigator in the area of immunology of infectious diseases and cytokine immunobiology. Dr. Sztein is a recognized international authority in the study of the human host systemic and mucosal immune responses to vaccination (with or without adjuvants) and the identification of immunological mechanisms of protection from infection in human and animal models, particularly in the field of infectious enteric diseases. Projects encompass the study of systemic and gastrointestinal mucosal immune responses in volunteers participating in challenge studies and in vaccine trials of genetically engineered vaccine strains such as attenuated Salmonella Typhi and Shigella (alone or as a carrier of foreign genes), Vibrio cholerae, Enteroaggregative E. coli, Plasmodium falciparum, Salmonella Paratyphi A and B, non-typhoidal Salmonella (NTS), invasive NTS, Dengue virus, Francisella tularensis, influenza, hepatitis and Ebola.
Chief Financial Officer
Contracts & Grants Specialist, Pre-Award
Contracts and Grants Specialist, Pre-Award
Contracts and Grants Specialist, Post Award
Khristy Bozylinski-Bulos, MS
Program Director, CVD
Nicole Eddington Johnson, MS, MPH
Diane Egorugwu, MPH
Senior Program Specialist
Deborah Ingram, MBA
Director of Finance
Carey Martin, MA, MBA
Director of Marketing and Public Relations
Executive Assistant to the Associate Dean for Global Health,
Vaccinology, and Infectious Diseases